Two-Year results of photodynamic therapy with or without intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 9, 2013, Pages 832-836

  Sakurada, Yoichi ^a   Iijima, Hiroyuki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; RANIBIZUMAB; VERTEPORFIN;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MULTIPLE REGRESSION; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID DISEASES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84887056868     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0044     Document Type: Article

References (26)

1. Spaide, R.F., Yannuzzi, L.A., Slakter, J.S., Sorenson, J., and Orlach, D.A. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15:100-110, 1995.
2. Bessho, H., Honda, S., Imai, H., and Negi, A. Natural course and funduscopic findings of polypoidal choroidal vasculopathy in a Japanese population over 1 year of follow-up. Retina 31:1598-1602, 2011.
3. Chan, W.M., Lam, D.S., Lai, T.Y., et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 111:1576-1584, 2004. (Pubitemid 39030815)
4. Spaide, R.F., Donsoff, I., Lam, D.L., et al. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina 22:529-535, 2002. (Pubitemid 35176066)
5. Silva, R.M., Figueira, J., Cachulo, M.L., Duarte, L., Faria de Abreu, J.R., and Cunha-Vaz, J.G. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch. Clin. Exp. Ophthalmol. 243:973-979, 2005. (Pubitemid 41631036)
6. Otani, A., Sasahara, M., Yodoi, Y., et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 144:7-14, 2007.
7. Hirami, Y., Tsujikawa, A., Otani, A., et al. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 27:335-341, 2007. (Pubitemid 46398898)
8. Kurashige, Y., Otani, A., Sasahara, M., et al. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 146:513-519, 2008.
9. Wakabayashi, T., Gomi, F., Sawa, M., Tsujikawa, M., and Tano, Y. Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy. Br. J. Ophthalmol. 92:936-940, 2008. (Pubitemid 351969674)
10. Kokame, G.T., Yeung, L., and Lai, J.C. Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br. J. Ophthalmol. 94:297-301, 2010.
11. Hikichi, T., Ohtsuka, H., Higuchi, M., et al. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months. Am. J. Ophthalmol. 150:674-682 e1, 2010.
12. Gomi, F., Sawa, M., Wakabayashi, T., Sasamoto, Y., Suzuki, M., and Tsujikawa, M. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 150:48-54 e1, 2010.
13. Sato, T., Kishi, S., Matsumoto, H., and Mukai, R. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 149:947-954 e1, 2010.
14. Ruamviboonsuk, P., Tadarati, M., Vanichvaranont, S., Hanutsaha, P., and Pokawattana, N. Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study. Br. J. Ophthalmol. 94:1045-1051, 2010.
15. Romano, M.R., Cipollone, U., Semeraro, F., Rinaldi, M., and Costagliola, C. Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up. Clin. Ophthalmol. 4:1237-1241, 2010.
16. Kim, S.J., and Yu, H.G. Efficacy of combined photodynamic therapy and intravitreal bevacizumab injection versus photodynamic therapy alone in polypoidal choroidal vasculopathy. Retina 31:1827-1834, 2011.
17. Lai, T.Y., Lee, G.K., Luk, F.O., and Lam, D.S. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy. Retina 31:1581-1588, 2011.
18. Lee, Y.H., Lee, E.K., Shin, K.S., Lee, K.M., and Kim, J.Y. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy. Retina 31:1287-1293, 2011.
19. Kim, M., Kim, K., Kim do G, Yu, S.Y., and Kwak, H.W. Twoyear results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy. Ophthalmologica 226: 205-213, 2011.
20. Lee, Y.A., Yang, C.H., Yang, C.M., et al. Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up. Am. J. Ophthalmol. 154:872-880 e2, 2012.
21. Nemoto, R., Miura, M., Iwasaki, T., and Goto, H. Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. Clin. Ophthalmol. 6:1633-1638, 2012.
22. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch. Ophthalmol. 117:1329-1345, 1999.
23. Tatar, O., Adam, A., Shinoda, K., et al. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am. J. Ophthalmol. 142: 95-104, 2006.
24. Mukai, R., Kishi, S., Sato, T.,Watanabe, G., andMatsumoto,H. Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy. Ophthalmologica 224:267-273, 2010.
25. Saito, M., Iida, T., and Kano, M. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation. Retina 31:1589-1597, 2011.
26. Tsujikawa, A., Ojima, Y., Yamashiro, K., et al. Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 151:961-972 e1, 2011.